Decision Counseling and Follow-up for Shield+ Patients
NCT07620535
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Colo-rectal Cancer
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 45 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Guardant Health, Inc.
- Last updated on ClinicalTrials.gov
- November 16, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Pennsylvania · 1
- Jefferson Center · Philadelphia, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.